8-K current report · filed Oct 20, 2026

Insmed Incorporated (INSM) 8-K Current Report: October 20, 2026

Item 5.02Item 7.01Item EX-99.1INSM overview

Short answer

Insmed Incorporated (INSM) filed an 8-K current report with the SEC on October 20, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Board expansion effective October 19, 2026: Paul Hudson, Class II, and Utpal Koppikar, Class I, stand for election in 2027.

Insmed Incorporated 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Board expansion effective October 19, 2026: Paul Hudson, Class II, and Utpal Koppikar, Class I, stand for election in 2027
  • Hudson adds global biopharma CEO experience, including Sanofi and Novartis Pharmaceuticals leadership
  • Koppikar adds senior biopharma finance expertise, currently serving as Verily CFO
  • Committee assignments strengthen oversight: Hudson joins Compensation, Koppikar joins Audit
  • Each director receives $65,000 annual cash, $12,500 committee retainer, and approximately $585,000 in RSUs vesting over three years

Item 7.01 · Regulation FD Disclosure

  • Press release announces appointments of Mr. Hudson and Mr. Koppikar
  • Leadership changes may affect strategic execution and investor expectations
  • Exhibit 99.1 contains the appointees’ titles, backgrounds and effective dates

Item EX-99.1 · Exhibit EX-99.1

  • Paul Hudson, former Sanofi and Novartis Pharmaceuticals CEO, appointed independent director effective immediately
  • Utpal Koppikar, Verily CFO and former Atara Biotherapeutics CFO, appointed independent director effective immediately
  • Board additions strengthen global commercialization, strategic transformation, financial management, and biopharma scaling expertise
  • Appointments support Insmed’s growth strategy as it advances approved therapies and mid- to late-stage pipeline programs

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Insmed Incorporated 8-K filings

Get the next INSM 8-K as it lands

Follow INSM for push alerts, or ask the research agent what this filing means.